Prati
Borivoj Galić
Borivoj Galić
Potvrđena adresa e-pošte na pmf.unsa.ba
Naslov
Citirano
Citirano
Godina
Advantages of an electrochemical method compared to the spectrophotometric kinetic study of peroxidase inhibition by boroxine derivative
J Ostojić, S Herenda, Z Bešić, M Miloš, B Galić
Molecules 22 (7), 1120, 2017
322017
Dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], is a potent inhibitor of human carbonic anhydrases
D Vullo, M Milos, B Galic, A Scozzafava, CT Supuran
Journal of Enzyme Inhibition and Medicinal Chemistry 30 (2), 341-344, 2015
312015
In vitro and in vivo antitumor activity of the halogenated boroxine dipotassium-trioxohydroxytetrafluorotriborate (K2 [B3O3F4OH])
S Ivankovic, R Stojkovic, Z Galic, B Galic, J Ostojic, M Marasovic, M Milos
Journal of enzyme inhibition and medicinal chemistry 30 (3), 354-359, 2015
262015
A study of the inhibition of catalase by dipotassium trioxohydroxytetrafluorotriborate K2 [B3O3F4OH]
S Islamovic, B Galic, M Milos
Journal of enzyme inhibition and medicinal chemistry 29 (5), 744-748, 2014
222014
Effects of dipotassium trioxohydroxytetrafluorotriborate (K2[B3O3F4OH]) on genetic material and inhibition of cell division in human cell cultures
S Haveric, A Haveric, K Bajrovic, B Galic, M Maksimovic
Drug and Chemical Toxicology 34 (3), 250-254, 2011
212011
Inhibitory effects of delphinidin and luteolin on genotoxicity induced by K2B3O3F4OH) in human lymphocytes in vitro
M Hadžić, S Haverić, A Haverić, B Galić
Biologia 70 (4), 553-558, 2015
162015
In vitro and in vivo antitumour effects of phenylboronic acid against mouse mammary adenocarcinoma 4T1 and squamous carcinoma SCCVII cells
M Marasovic, S Ivankovic, R Stojkovic, D Djermic, B Galic, M Milos
Journal of enzyme inhibition and medicinal chemistry 32 (1), 1299-1304, 2017
152017
Boroxine composition for removal of skin changes
B Galic
Patent US 8, 278-289, 2012
132012
Inhibition of horseradish peroxidase activity by boroxine derivative, dipotassium-trioxohydroxytetrafluorotriborate K2 [B3O3F4OH]
J Ostojic, S Herenda, S Galijasevic, B Galic, M Milos
Journal of Chemistry 2017, 2017
122017
Electrochemical investigation of the influence of K2 [B3O3F4OH] on the activity of immobilized superoxide dismutase
S Herenda, J Ostojić, E Hasković, D Hasković, M Miloš, B Galić
Int. J. Electrochem. Sci 13, 3279-3287, 2018
82018
Effects of dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], on cell viability and gene expression of common human cancer drug targets in a …
L Pojskic, S Haveric, N Lojo-Kadric, M Hadzic, A Haveric, Z Galic, B Galic, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 31 (6), 999-1004, 2016
72016
Bioflavonoids protect cells against halogenated boroxine-induced genotoxic damage by upregulation of hTERT expression
M Hadzic, S Haveric, A Haveric, N Lojo-Kadric, B Galic, J Ramic, L Pojskic
Zeitschrift für Naturforschung C 74 (5-6), 125-129, 2019
62019
Impact of calcium ion on cytotoxic effect of the boroxine derivative, K2[B3O3F4OH]
S Ivankovic, R Stojkovic, M Maksimovic, B Galic, M Milos
Journal of Enzyme Inhibition and Medicinal Chemistry 31 (sup3), 70-74, 2016
62016
Halogenated boroxine dipotassium trioxohydroxytetrafluorotriborate K2[B3O3F4OH] inhibits emerging multidrug-resistant and β-lactamase-producing …
A Maravić, T Rončević, L Krce, N Ilić, B Galić, V Čulić Čikeš, I Carev
Drug Development and Industrial Pharmacy 45 (11), 1770-1776, 2019
52019
Genotoxicity evaluation of dipotassium-trioxohydroxytetrafluorotriborate, K2 (B3O3F4OH), in human lymphocyte cultures and mice reticulocytes
S Haveric, M Hadzic, A Haveric, M Mijanovic, R Hadziselimovic, B Galic
Brazilian Archives of Biology and Technology 59, 2016
42016
Boroxine composition for removal of skin changes
B Galic
US Patent 8,278,289, 2012
42012
Biochemical and histomorphological findings in Swiss Wistar rats treated with potential boron-containing therapeutic-K2 [B3O3F4OH]
A Haverić, A Durmić-Pašić, A Alić, I Mujezinović, A Smajlović, J Ostojić, ...
Journal of Trace Elements in Medicine and Biology 62, 126642, 2020
32020
Quantum Chemical and Biochemical Study on Antioxidant Properties of Halogenated Boroxine [K. sub. 2][[B. sub. 3][O. sub. 3][F. sub. 4] OH]
M Marasovic, T Marasovic, B Galic, M Milos
Croatica chemica acta 90 (2), F1-F1, 2017
32017
Determination Of Antioxidant Capacity Of Selected Boroxines
M Marasović, A Roščić, B Galić, M Miloš
CBU International Conference Proceedings 5, 1159-1163, 2017
12017
Study of kinetic parameters and possible inhibitory effect on the tyrosinase of the halogenated boroxine dipotassium trioxohydroxytetrafluorotriborate K2 [B303F4OH]
M Marasović, Z Čorić, M Miloš, B Galić
CBU International Conference Proceedings 4, 700-705, 2016
12016
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20